The European Medicines Agency (EMA) has established a new advisory group on vaccine confidence aimed at tackling vaccine hesitancy and improving public understanding of immunisation.
According to an EMA press release, the panel, composed of more than 20 high-level European and international experts, held its first meeting on 29 April.
The Agency highlighted that vaccine hesitancy is an increasing global threat to public health, warning that declining trust can lead to the re-emergence of infectious diseases and put lives at risk.
EMA said it has a key role in providing transparent, evidence-based information and clearly explaining the science behind vaccine approvals to support informed decision-making.
The newly established group brings together leading voices in the field and is expected to play a central role in rebuilding trust, protecting communities and supporting public health efforts.
The advisory group will meet on a quarterly basis and includes academics, healthcare professionals, representatives of medical societies and patient organisations, as well as public health bodies.
Its main objectives include assessing the current landscape of vaccine hesitancy, advising on EMA initiatives to boost vaccine confidence, improving communication on the benefits and risks of vaccines, and strengthening the Agency’s public outreach.
The initiative forms part of EMA’s broader Vaccine Outreach Strategy, which seeks to enhance knowledge and trust in the quality, safety and effectiveness of vaccines, while supporting both the public and healthcare professionals in making informed vaccination decisions.
Source: CNA